Top

Reactions Weekly

Published in:

01-03-2024 | NSCLC | Case report

Multiple drugs

Hepatitis and neutropenia

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Xia R, et al. Immunotherapy or antiangiogenic therapy plus chemotherapy as first-line treatment of patients with PD-L1(-) advanced non-squamous non-small cell lung cancer in a Chinese cohort. Cancer Medicine 12 : 14282-14292, No. 13, Jul 2023. Available from: URL: https://dx.doi.org/10.1002/cam4.6101

Title: Multiple drugs
Hepatitis and neutropenia
Publication date: 01-03-2024
Publisher: Springer International Publishing
Keywords: NSCLC
NSCLC
Neutropenia
Bevacizumab
Hepatitis
Folic Acid
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-55257-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Multiple drugs

Hepatitis and neutropenia

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Hydroxychloroquine in SLE/RA pregnancy: no significantly increased risk of major congenital malformations

Heparin

Ibrutinib

Omeprazole/Tacrolimus interaction

Tozinameran

Cefotaxime